Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Serious adverse events are rare in published literature
Key Findings: Participants: 338 obese adults Duration: 48 weeks Average weight loss: 17.5% to 24.2% depending on dose Metabolic improvements: Better insulin sensitivity, reduced inflammation markers These results put Retatrutide ahead of many current obesity drugs, making it one of the most promising new weight loss peptides of 2025
71 LombardK
Improved Blood Sugar Control Particularly beneficial for individuals with insulin resistance or type 2 diabetes
In one study sponsored by GOLO, 34 people diagnosed with obesity followed the GOLO meal plan for 13 weeks
US$ 25.09
US$ 28.83
US$ 24.88
US$ 29.83
